<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 19:01:58 -0700</creation_date>
  <update_date>2013-05-27 11:35:42 -0600</update_date>
  <accession>HMDBP02053</accession>
  <secondary_accessions>
    <accession>7532</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>Superoxide dismutase 1</synonym>
    <synonym>hSod1</synonym>
  </synonyms>
  <gene_name>SOD1</gene_name>
  <general_function>Involved in metal ion binding</general_function>
  <specific_function>Destroys radicals which are normally produced within the cells and which are toxic to biological systems.
</specific_function>
  <pathways>
    <pathway>
      <name>Peroxisome</name>
      <smpdb_id/>
      <kegg_map_id>map04146</kegg_map_id>
    </pathway>
    <pathway>
      <name>Amyotrophic lateral sclerosis (ALS)</name>
      <smpdb_id/>
      <kegg_map_id>map05014</kegg_map_id>
    </pathway>
    <pathway>
      <name>Huntington's disease</name>
      <smpdb_id/>
      <kegg_map_id>map05016</kegg_map_id>
    </pathway>
    <pathway>
      <name>Prion diseases</name>
      <smpdb_id/>
      <kegg_map_id>map05020</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00657</accession>
      <name>Copper</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00692</accession>
      <name>Fe2+</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01303</accession>
      <name>Zinc (II) ion</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01333</accession>
      <name>Manganese</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01377</accession>
      <name>Oxygen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02168</accession>
      <name>Superoxide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03125</accession>
      <name>Hydrogen peroxide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01893</accession>
      <name>Alpha-Tocopherol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB59597</accession>
      <name>Hydrogen Ion</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>ion binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>cation binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>metal ion binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>oxidation reduction</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>cellular metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>oxygen and reactive oxygen species metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>superoxide metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytoplasmic vesicle</description>
      <go_id>GO:0031410</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytosol</description>
      <go_id>GO:0005829</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>dendrite cytoplasm</description>
      <go_id>GO:0032839</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>extracellular matrix</description>
      <go_id>GO:0031012</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>extracellular space</description>
      <go_id>GO:0005615</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>mitochondrial matrix</description>
      <go_id>GO:0005759</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>neuronal cell body</description>
      <go_id>GO:0043025</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>nucleus</description>
      <go_id>GO:0005634</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>peroxisome</description>
      <go_id>GO:0005777</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>protein complex</description>
      <go_id>GO:0043234</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>copper ion binding</description>
      <go_id>GO:0005507</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>protein homodimerization activity</description>
      <go_id>GO:0042803</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>protein phosphatase 2B binding</description>
      <go_id>GO:0030346</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>superoxide dismutase activity</description>
      <go_id>GO:0004784</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>zinc ion binding</description>
      <go_id>GO:0008270</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>activation of MAPK activity</description>
      <go_id>GO:0000187</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>anterograde axon cargo transport</description>
      <go_id>GO:0008089</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>apoptotic DNA fragmentation</description>
      <go_id>GO:0006309</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>auditory receptor cell stereocilium organization</description>
      <go_id>GO:0060088</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cell aging</description>
      <go_id>GO:0007569</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular iron ion homeostasis</description>
      <go_id>GO:0006879</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>double-strand break repair</description>
      <go_id>GO:0006302</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>embryo implantation</description>
      <go_id>GO:0007566</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>glutathione metabolic process</description>
      <go_id>GO:0006749</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>heart contraction</description>
      <go_id>GO:0060047</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>hydrogen peroxide biosynthetic process</description>
      <go_id>GO:0050665</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>locomotory behavior</description>
      <go_id>GO:0007626</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>muscle cell homeostasis</description>
      <go_id>GO:0046716</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>myeloid cell homeostasis</description>
      <go_id>GO:0002262</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of cholesterol biosynthetic process</description>
      <go_id>GO:0045541</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of neuron apoptotic process</description>
      <go_id>GO:0043524</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>neurofilament cytoskeleton organization</description>
      <go_id>GO:0060052</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>ovarian follicle development</description>
      <go_id>GO:0001541</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>peripheral nervous system myelin maintenance</description>
      <go_id>GO:0032287</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>placenta development</description>
      <go_id>GO:0001890</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>platelet activation</description>
      <go_id>GO:0030168</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>platelet degranulation</description>
      <go_id>GO:0002576</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of apoptotic process</description>
      <go_id>GO:0043065</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of cytokine production</description>
      <go_id>GO:0001819</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of blood pressure</description>
      <go_id>GO:0008217</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of mitochondrial membrane potential</description>
      <go_id>GO:0051881</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of multicellular organism growth</description>
      <go_id>GO:0040014</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of organ growth</description>
      <go_id>GO:0046620</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of T cell differentiation in thymus</description>
      <go_id>GO:0033081</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>relaxation of vascular smooth muscle</description>
      <go_id>GO:0060087</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>removal of superoxide radicals</description>
      <go_id>GO:0019430</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to amphetamine</description>
      <go_id>GO:0001975</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to axon injury</description>
      <go_id>GO:0048678</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to copper ion</description>
      <go_id>GO:0046688</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to drug</description>
      <go_id>GO:0042493</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to ethanol</description>
      <go_id>GO:0045471</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to heat</description>
      <go_id>GO:0009408</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to hydrogen peroxide</description>
      <go_id>GO:0042542</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to nutrient levels</description>
      <go_id>GO:0031667</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>retina homeostasis</description>
      <go_id>GO:0001895</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>retrograde axon cargo transport</description>
      <go_id>GO:0008090</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>sensory perception of sound</description>
      <go_id>GO:0007605</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>spermatogenesis</description>
      <go_id>GO:0007283</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>superoxide anion generation</description>
      <go_id>GO:0042554</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>thymus development</description>
      <go_id>GO:0048538</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Cytoplasm</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>21</chromosome_location>
    <locus>21q22.11</locus>
    <gene_sequence>&gt;465 bp
ATGGCGACGAAGGCCGTGTGCGTGCTGAAGGGCGACGGCCCAGTGCAGGGCATCATCAAT
TTCGAGCAGAAGGAAAGTAATGGACCAGTGAAGGTGTGGGGAAGCATTAAAGGACTGACT
GAAGGCCTGCATGGATTCCATGTTCATGAGTTTGGAGATAATACAGCAGGCTGTACCAGT
GCAGGTCCTCACTTTAATCCTCTATCCAGAAAACACGGTGGGCCAAAGGATGAAGAGAGG
CATGTTGGAGACTTGGGCAATGTGACTGCTGACAAAGATGGTGTGGCCGATGTGTCTATT
GAAGATTCTGTGATCTCACTCTCAGGAGACCATTGCATCATTGGCCGCACACTGGTGGTC
CATGAAAAAGCAGATGACTTGGGCAAAGGTGGAAATGAAGAAAGTACAAAGACAGGAAAC
GCTGGAAGTCGTTTGGCTTGTGGTGTAATTGGGATCGCCCAATAA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>154</residue_number>
    <molecular_weight>15935.685</molecular_weight>
    <theoretical_pi>6.122</theoretical_pi>
    <pfams>
      <pfam>
        <name>Sod_Cu</name>
        <pfam_id>PF00080</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Superoxide dismutase [Cu-Zn]
MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTS
AGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVV
HEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ</protein_sequence>
  </protein_properties>
  <genbank_protein_id>36542</genbank_protein_id>
  <uniprot_id>P00441</uniprot_id>
  <uniprot_name>SODC_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1AZV</pdb_id>
    <pdb_id>1BA9</pdb_id>
    <pdb_id>1DSW</pdb_id>
    <pdb_id>1FUN</pdb_id>
    <pdb_id>1HL4</pdb_id>
    <pdb_id>1HL5</pdb_id>
    <pdb_id>1KMG</pdb_id>
    <pdb_id>1L3N</pdb_id>
    <pdb_id>1MFM</pdb_id>
    <pdb_id>1N18</pdb_id>
    <pdb_id>1N19</pdb_id>
    <pdb_id>1OEZ</pdb_id>
    <pdb_id>1OZT</pdb_id>
    <pdb_id>1OZU</pdb_id>
    <pdb_id>1P1V</pdb_id>
    <pdb_id>1PTZ</pdb_id>
    <pdb_id>1PU0</pdb_id>
    <pdb_id>1RK7</pdb_id>
    <pdb_id>1SOS</pdb_id>
    <pdb_id>1SPD</pdb_id>
    <pdb_id>1UXL</pdb_id>
    <pdb_id>1UXM</pdb_id>
    <pdb_id>2AF2</pdb_id>
    <pdb_id>2C9S</pdb_id>
    <pdb_id>2C9U</pdb_id>
    <pdb_id>2C9V</pdb_id>
    <pdb_id>2GBT</pdb_id>
    <pdb_id>2GBU</pdb_id>
    <pdb_id>2GBV</pdb_id>
    <pdb_id>2LU5</pdb_id>
    <pdb_id>2NNX</pdb_id>
    <pdb_id>2R27</pdb_id>
    <pdb_id>2V0A</pdb_id>
    <pdb_id>2VR6</pdb_id>
    <pdb_id>2VR7</pdb_id>
    <pdb_id>2VR8</pdb_id>
    <pdb_id>2WKO</pdb_id>
    <pdb_id>2WYT</pdb_id>
    <pdb_id>2WYZ</pdb_id>
    <pdb_id>2WZ0</pdb_id>
    <pdb_id>2WZ5</pdb_id>
    <pdb_id>2WZ6</pdb_id>
    <pdb_id>2XJK</pdb_id>
    <pdb_id>2XJL</pdb_id>
    <pdb_id>2ZKW</pdb_id>
    <pdb_id>2ZKX</pdb_id>
    <pdb_id>2ZKY</pdb_id>
    <pdb_id>3CQP</pdb_id>
    <pdb_id>3CQQ</pdb_id>
    <pdb_id>3ECU</pdb_id>
    <pdb_id>3ECV</pdb_id>
    <pdb_id>3ECW</pdb_id>
    <pdb_id>3GQF</pdb_id>
    <pdb_id>3GTV</pdb_id>
    <pdb_id>3GZO</pdb_id>
    <pdb_id>3GZP</pdb_id>
    <pdb_id>3GZQ</pdb_id>
    <pdb_id>3H2P</pdb_id>
    <pdb_id>3H2Q</pdb_id>
    <pdb_id>3HFF</pdb_id>
    <pdb_id>3K91</pdb_id>
    <pdb_id>3KH3</pdb_id>
    <pdb_id>3KH4</pdb_id>
    <pdb_id>3LTV</pdb_id>
    <pdb_id>3QQD</pdb_id>
    <pdb_id>3RE0</pdb_id>
    <pdb_id>3T5W</pdb_id>
    <pdb_id>4A7G</pdb_id>
    <pdb_id>4A7Q</pdb_id>
    <pdb_id>4A7S</pdb_id>
    <pdb_id>4A7T</pdb_id>
    <pdb_id>4A7U</pdb_id>
    <pdb_id>4A7V</pdb_id>
    <pdb_id>4B3E</pdb_id>
    <pdb_id>4SOD</pdb_id>
  </pdb_ids>
  <genbank_gene_id>X02317</genbank_gene_id>
  <genecard_id>SOD1</genecard_id>
  <geneatlas_id>SOD1</geneatlas_id>
  <hgnc_id>HGNC:11179</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Sherman L, Dafni N, Lieman-Hurwitz J, Groner Y: Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5465-9.</reference_text>
      <pubmed_id>6577438</pubmed_id>
    </reference>
    <reference>
      <reference_text>Levanon D, Lieman-Hurwitz J, Dafni N, Wigderson M, Sherman L, Bernstein Y, Laver-Rudich Z, Danciger E, Stein O, Groner Y: Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J. 1985 Jan;4(1):77-84.</reference_text>
      <pubmed_id>3160582</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hallewell RA, Masiarz FR, Najarian RC, Puma JP, Quiroga MR, Randolph A, Sanchez-Pescador R, Scandella CJ, Smith B, Steimer KS, et al.: Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res. 1985 Mar 25;13(6):2017-34.</reference_text>
      <pubmed_id>3889846</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kajihara J, Enomoto M, Nishijima K, Yabuuchi M, Katoh K: Comparison of properties between human recombinant and placental copper-zinc SOD. J Biochem (Tokyo). 1988 Nov;104(5):851-4.</reference_text>
      <pubmed_id>2853161</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, Toyoda A, Ishii K, Totoki Y, Choi DK, Groner Y, Soeda E, Ohki M, Takagi T, Sakaki Y, Taudien S, Blechschmidt K, Polley A, Menzel U, Delabar J, Kumpf K, Lehmann R, Patterson D, Reichwald K, Rump A, Schillhabel M, Schudy A, Zimmermann W, Rosenthal A, Kudoh J, Schibuya K, Kawasaki K, Asakawa S, Shintani A, Sasaki T, Nagamine K, Mitsuyama S, Antonarakis SE, Minoshima S, Shimizu N, Nordsiek G, Hornischer K, Brant P, Scharfe M, Schon O, Desario A, Reichelt J, Kauer G, Blocker H, Ramser J, Beck A, Klages S, Hennig S, Riesselmann L, Dagand E, Haaf T, Wehrmeyer S, Borzym K, Gardiner K, Nizetic D, Francis F, Lehrach H, Reinhardt R, Yaspo ML: The DNA sequence of human chromosome 21.  Nature. 2000 May 18;405(6784):311-9.</reference_text>
      <pubmed_id>10830953</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Jabusch JR, Farb DL, Kerschensteiner DA, Deutsch HF: Some sulfhydryl properties and primary structure of human erythrocyte superoxide dismutase. Biochemistry. 1980 May 27;19(11):2310-6.</reference_text>
      <pubmed_id>6770891</pubmed_id>
    </reference>
    <reference>
      <reference_text>Barra D, Martini F, Bannister JV, Schinina ME, Rotilio G, Bannister WH, Bossa F: The complete amino acid sequence of human Cu/Zn superoxide dismutase.  FEBS Lett. 1980 Oct 20;120(1):53-6.</reference_text>
      <pubmed_id>7002610</pubmed_id>
    </reference>
    <reference>
      <reference_text>Enayat ZE, Orrell RW, Claus A, Ludolph A, Bachus R, Brockmuller J, Ray-Chaudhuri K, Radunovic A, Shaw C, Wilkinson J, et al.: Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet. 1995 Jul;4(7):1239-40.</reference_text>
      <pubmed_id>8528216</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kostrzewa M, Damian MS, Muller U: Superoxide dismutase 1: identification of a novel mutation in a case of familial amyotrophic lateral sclerosis. Hum Genet. 1996 Jul;98(1):48-50.</reference_text>
      <pubmed_id>8682505</pubmed_id>
    </reference>
    <reference>
      <reference_text>Arnesano F, Banci L, Bertini I, Martinelli M, Furukawa Y, O'Halloran TV: The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J Biol Chem. 2004 Nov 12;279(46):47998-8003. Epub 2004 Aug 23.</reference_text>
      <pubmed_id>15326189</pubmed_id>
    </reference>
    <reference>
      <reference_text>Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation.  Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. Epub 2008 Jul 31.</reference_text>
      <pubmed_id>18669648</pubmed_id>
    </reference>
    <reference>
      <reference_text>Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40. Epub 2009 Jul 16.</reference_text>
      <pubmed_id>19608861</pubmed_id>
    </reference>
    <reference>
      <reference_text>Parge HE, Hallewell RA, Tainer JA: Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6109-13.</reference_text>
      <pubmed_id>1463506</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hart PJ, Liu H, Pellegrini M, Nersissian AM, Gralla EB, Valentine JS, Eisenberg D: Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci. 1998 Mar;7(3):545-55.</reference_text>
      <pubmed_id>9541385</pubmed_id>
    </reference>
    <reference>
      <reference_text>Banci L, Benedetto M, Bertini I, Del Conte R, Piccioli M, Viezzoli MS: Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme?. Biochemistry. 1998 Aug 25;37(34):11780-91.</reference_text>
      <pubmed_id>9718300</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ferraroni M, Rypniewski W, Wilson KS, Viezzoli MS, Banci L, Bertini I, Mangani S: The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisited. J Mol Biol. 1999 May 7;288(3):413-26.</reference_text>
      <pubmed_id>10329151</pubmed_id>
    </reference>
    <reference>
      <reference_text>Banci L, Bertini I, Cramaro F, Del Conte R, Viezzoli MS: Solution structure of Apo Cu,Zn superoxide dismutase: role of metal ions in protein folding. Biochemistry. 2003 Aug 19;42(32):9543-53.</reference_text>
      <pubmed_id>12911296</pubmed_id>
    </reference>
    <reference>
      <reference_text>DiDonato M, Craig L, Huff ME, Thayer MM, Cardoso RM, Kassmann CJ, Lo TP, Bruns CK, Powers ET, Kelly JW, Getzoff ED, Tainer JA: ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol. 2003 Sep 19;332(3):601-15.</reference_text>
      <pubmed_id>12963370</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, Hasnain SS, Hayward LJ, Valentine JS, Yeates TO, Hart PJ: Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol. 2003 Jun;10(6):461-7.</reference_text>
      <pubmed_id>12754496</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hough MA, Grossmann JG, Antonyuk SV, Strange RW, Doucette PA, Rodriguez JA, Whitson LJ, Hart PJ, Hayward LJ, Valentine JS, Hasnain SS: Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5976-81. Epub 2004 Mar 31.</reference_text>
      <pubmed_id>15056757</pubmed_id>
    </reference>
    <reference>
      <reference_text>Banci L, Bertini I, Cantini F, D'Amelio N, Gaggelli E: Human SOD1 before harboring the catalytic metal: solution structure of copper-depleted, disulfide-reduced form. J Biol Chem. 2006 Jan 27;281(4):2333-7. Epub 2005 Nov 14.</reference_text>
      <pubmed_id>16291742</pubmed_id>
    </reference>
    <reference>
      <reference_text>Strange RW, Antonyuk SV, Hough MA, Doucette PA, Valentine JS, Hasnain SS: Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J Mol Biol. 2006 Mar 10;356(5):1152-62. Epub 2005 Dec 12.</reference_text>
      <pubmed_id>16406071</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hornberg A, Logan DT, Marklund SL, Oliveberg M: The coupling between disulphide status, metallation and dimer interface strength in Cu/Zn superoxide dismutase. J Mol Biol. 2007 Jan 12;365(2):333-42. Epub 2006 Sep 23.</reference_text>
      <pubmed_id>17070542</pubmed_id>
    </reference>
    <reference>
      <reference_text>Roberts BR, Tainer JA, Getzoff ED, Malencik DA, Anderson SR, Bomben VC, Meyers KR, Karplus PA, Beckman JS: Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J Mol Biol. 2007 Nov 2;373(4):877-90. Epub 2007 Aug 2.</reference_text>
      <pubmed_id>17888947</pubmed_id>
    </reference>
    <reference>
      <reference_text>Strange RW, Yong CW, Smith W, Hasnain SS: Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu-Zn superoxide dismutase. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10040-4. Epub 2007 Jun 4.</reference_text>
      <pubmed_id>17548825</pubmed_id>
    </reference>
    <reference>
      <reference_text>Cao X, Antonyuk SV, Seetharaman SV, Whitson LJ, Taylor AB, Holloway SP, Strange RW, Doucette PA, Valentine JS, Tiwari A, Hayward LJ, Padua S, Cohlberg JA, Hasnain SS, Hart PJ: Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis. J Biol Chem. 2008 Jun 6;283(23):16169-77. Epub 2008 Mar 31.</reference_text>
      <pubmed_id>18378676</pubmed_id>
    </reference>
    <reference>
      <reference_text>de Belleroche J, Orrell R, King A: Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet. 1995 Nov;32(11):841-7.</reference_text>
      <pubmed_id>8592323</pubmed_id>
    </reference>
    <reference>
      <reference_text>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59-62.</reference_text>
      <pubmed_id>8446170</pubmed_id>
    </reference>
    <reference>
      <reference_text>Rosen DR: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Jul 22;364(6435):362.</reference_text>
      <pubmed_id>8332197</pubmed_id>
    </reference>
    <reference>
      <reference_text>Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, et al.: Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993 Aug 20;261(5124):1047-51.</reference_text>
      <pubmed_id>8351519</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nakano R, Sato S, Inuzuka T, Sakimura K, Mishina M, Takahashi H, Ikuta F, Honma Y, Fujii J, Taniguchi N, et al.: A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 1994 Apr 29;200(2):695-703.</reference_text>
      <pubmed_id>8179602</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hirano M, Fujii J, Nagai Y, Sonobe M, Okamoto K, Araki H, Taniguchi N, Ueno S: A new variant Cu/Zn superoxide dismutase (Val7--&amp;gt;Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 1994 Oct 28;204(2):572-7.</reference_text>
      <pubmed_id>7980516</pubmed_id>
    </reference>
    <reference>
      <reference_text>Jones CT, Swingler RJ, Brock DJ: Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet. 1994 Apr;3(4):649-50.</reference_text>
      <pubmed_id>8069312</pubmed_id>
    </reference>
    <reference>
      <reference_text>Esteban J, Rosen DR, Bowling AC, Sapp P, McKenna-Yasek D, O'Regan JP, Beal MF, Horvitz HR, Brown RH Jr: Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet. 1994 Jun;3(6):997-8.</reference_text>
      <pubmed_id>7951252</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kostrzewa M, Burck-Lehmann U, Muller U: Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene. Hum Mol Genet. 1994 Dec;3(12):2261-2.</reference_text>
      <pubmed_id>7881433</pubmed_id>
    </reference>
    <reference>
      <reference_text>Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, Abe K: Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci. 1994 Oct;126(1):77-83.</reference_text>
      <pubmed_id>7836951</pubmed_id>
    </reference>
    <reference>
      <reference_text>Suthers G, Laing N, Wilton S, Dorosz S, Waddy H: &amp;quot;Sporadic&amp;quot; motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet. 1994 Dec 24-31;344(8939-8940):1773.</reference_text>
      <pubmed_id>7997024</pubmed_id>
    </reference>
    <reference>
      <reference_text>Jones CT, Shaw PJ, Chari G, Brock DJ: Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes. 1994 Aug;8(4):329-30.</reference_text>
      <pubmed_id>7870076</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pramatarova A, Figlewicz DA, Krizus A, Han FY, Ceballos-Picot I, Nicole A, Dib M, Meininger V, Brown RH, Rouleau GA: Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet. 1995 Mar;56(3):592-6.</reference_text>
      <pubmed_id>7887412</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ikeda M, Abe K, Aoki M, Ogasawara M, Kameya T, Watanabe M, Shoji M, Hirai S, Itoyama Y: A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet. 1995 Mar;4(3):491-2.</reference_text>
      <pubmed_id>7795609</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EM: An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet. 1995 Jun;4(6):1101-4.</reference_text>
      <pubmed_id>7655468</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sjalander A, Beckman G, Deng HX, Iqbal Z, Tainer JA, Siddique T: The D90A mutation results in a polymorphism of Cu,Zn superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet. 1995 Jun;4(6):1105-8.</reference_text>
      <pubmed_id>7655469</pubmed_id>
    </reference>
    <reference>
      <reference_text>Deng HX, Tainer JA, Mitsumoto H, Ohnishi A, He X, Hung WY, Zhao Y, Juneja T, Hentati A, Siddique T: Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis. Hum Mol Genet. 1995 Jun;4(6):1113-6.</reference_text>
      <pubmed_id>7655471</pubmed_id>
    </reference>
    <reference>
      <reference_text>Orrell R, de Belleroche J, Marklund S, Bowe F, Hallewell R: A novel SOD mutant and ALS.  Nature. 1995 Apr 6;374(6522):504-5.</reference_text>
      <pubmed_id>7700376</pubmed_id>
    </reference>
    <reference>
      <reference_text>Andersen PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T, Nilsson L, Binzer M, Forsgren L, Marklund SL: Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet. 1995 May;10(1):61-6.</reference_text>
      <pubmed_id>7647793</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ikeda M, Abe K, Aoki M, Sahara M, Watanabe M, Shoji M, St George-Hyslop PH, Hirai S, Itoyama Y: Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neurology. 1995 Nov;45(11):2038-42.</reference_text>
      <pubmed_id>7501156</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sapp PC, Rosen DR, Hosler BA, Esteban J, McKenna-Yasek D, O'Regan JP, Horvitz HR, Brown RH Jr: Identification of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord. 1995 Sep;5(5):353-7.</reference_text>
      <pubmed_id>7496169</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hosler BA, Nicholson GA, Sapp PC, Chin W, Orrell RW, de Belleroche JS, Esteban J, Hayward LJ, Mckenna-Yasek D, Yeung L, Cherryson AK, Dench JE, Wilton SD, Laing NG, Horvitz RH, Brown RH Jr: Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromuscul Disord. 1996 Oct;6(5):361-6.</reference_text>
      <pubmed_id>8938700</pubmed_id>
    </reference>
    <reference>
      <reference_text>Morita M, Aoki M, Abe K, Hasegawa T, Sakuma R, Onodera Y, Ichikawa N, Nishizawa M, Itoyama Y: A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci Lett. 1996 Feb 23;205(2):79-82.</reference_text>
      <pubmed_id>8907321</pubmed_id>
    </reference>
    <reference>
      <reference_text>Watanabe M, Aoki M, Abe K, Shoji M, Iizuka T, Ikeda Y, Hirai S, Kurokawa K, Kato T, Sasaki H, Itoyama Y: A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familial motor neuron disease. Hum Mutat. 1997;9(1):69-71.</reference_text>
      <pubmed_id>8990014</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kawamata J, Shimohama S, Takano S, Harada K, Ueda K, Kimura J: Novel G16S (GGC-AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis. Hum Mutat. 1997;9(4):356-8.</reference_text>
      <pubmed_id>9101297</pubmed_id>
    </reference>
    <reference>
      <reference_text>Orrell RW, Marklund SL, deBelleroche JS: Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser). J Neurol Sci. 1997 Dec 9;153(1):46-9.</reference_text>
      <pubmed_id>9455977</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kikugawa K, Nakano R, Inuzuka T, Kokubo Y, Narita Y, Kuzuhara S, Yoshida S, Tsuji S: A missense mutation in the SOD1 gene in patients with amyotrophic lateral sclerosis from the Kii Peninsula and its vicinity, Japan. Neurogenetics. 1997 Sep;1(2):113-5.</reference_text>
      <pubmed_id>10732812</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bereznai B, Winkler A, Borasio GD, Gasser T: A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromuscul Disord. 1997 Mar;7(2):113-6.</reference_text>
      <pubmed_id>9131652</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, Culotta VC, Borchelt DR: Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet. 1999 Aug;8(8):1451-60.</reference_text>
      <pubmed_id>10400992</pubmed_id>
    </reference>
    <reference>
      <reference_text>Penco S, Schenone A, Bordo D, Bolognesi M, Abbruzzese M, Bugiani O, Ajmar F, Garre C: A SOD1 gene mutation in a patient with slowly progressing familial ALS.  Neurology. 1999 Jul 22;53(2):404-6.</reference_text>
      <pubmed_id>10430435</pubmed_id>
    </reference>
    <reference>
      <reference_text>Murakami T, Warita H, Hayashi T, Sato K, Manabe Y, Mizuno S, Yamane K, Abe K: A novel SOD1 gene mutation in familial ALS with low penetrance in females.  J Neurol Sci. 2001 Aug 15;189(1-2):45-7.</reference_text>
      <pubmed_id>11535232</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gellera C, Castellotti B, Riggio MC, Silani V, Morandi L, Testa D, Casali C, Taroni F, Di Donato S, Zeviani M, Mariotti C: Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations. Neuromuscul Disord. 2001 May;11(4):404-10.</reference_text>
      <pubmed_id>11369193</pubmed_id>
    </reference>
    <reference>
      <reference_text>Alexander MD, Traynor BJ, Miller N, Corr B, Frost E, McQuaid S, Brett FM, Green A, Hardiman O: &amp;quot;True&amp;quot; sporadic ALS associated with a novel SOD-1 mutation.  Ann Neurol. 2002 Nov;52(5):680-3.</reference_text>
      <pubmed_id>12402272</pubmed_id>
    </reference>
    <reference>
      <reference_text>Niwa J, Ishigaki S, Hishikawa N, Yamamoto M, Doyu M, Murata S, Tanaka K, Taniguchi N, Sobue G: Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J Biol Chem. 2002 Sep 27;277(39):36793-8. Epub 2002 Jul 26.</reference_text>
      <pubmed_id>12145308</pubmed_id>
    </reference>
    <reference>
      <reference_text>Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, Pioro E, Harati Y, Brower RD, Levine JS, Heinicke HU, Seltzer W, Boss M, Brown RH Jr: Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):62-73.</reference_text>
      <pubmed_id>14506936</pubmed_id>
    </reference>
    <reference>
      <reference_text>Furukawa Y, Kaneko K, Yamanaka K, O'Halloran TV, Nukina N: Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J Biol Chem. 2008 Aug 29;283(35):24167-76. Epub 2008 Jun 13.</reference_text>
      <pubmed_id>18552350</pubmed_id>
    </reference>
    <reference>
      <reference_text>Banci L, Bertini I, Boca M, Girotto S, Martinelli M, Valentine JS, Vieru M: SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization.  PLoS One. 2008 Feb 27;3(2):e1677.</reference_text>
      <pubmed_id>18301754</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yonashiro R, Sugiura A, Miyachi M, Fukuda T, Matsushita N, Inatome R, Ogata Y, Suzuki T, Dohmae N, Yanagi S: Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. Mol Biol Cell. 2009 Nov;20(21):4524-30. Epub 2009 Sep 9.</reference_text>
      <pubmed_id>19741096</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Alpha-Tocopherol</name>
        <accession>HMDB01893</accession>
      </metabolite>
      <reference>
        <reference_text>Feng Z, Liu Z, Li X, Jia H, Sun L, Tian C, Jia L, Liu J: alpha-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J Nutr Biochem. 2010 Dec;21(12):1222-31. Epub 2010 Feb 12.</reference_text>
        <pubmed_id>20153624</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
